#Japan #healthcare #Tokyo #Medical Tribune #Alfresa

Strategic Collaboration Between Medical Tribune and Alfresa

In an effort to meet the evolving information needs of medical professionals and support daily clinical practice, Medical Tribune Co., Ltd. has announced a strategic business partnership with Alfresa Corporation. This collaboration aims to promote healthcare digital transformation (DX) and create new services tailored for the medical community.

Background of the Partnership

The healthcare industry is facing increasing demand for enhanced and efficient information delivery, as well as the establishment of a high-precision information distribution system. Alfresa, with its robust real-world network connecting medical institutions and pharmacies, has developed a digital platform named "Mydodes" that links healthcare providers with medical representatives (MRs).

On the other hand, Medical Tribune has established itself as a pioneer in medical media, boasting a membership base of around 300,000 individuals across both print and web platforms, fostering deep relationships with physicians.

Commencing in November 2023, both companies will collaborate on building and jointly implementing a digital platform for physicians. This partnership is recognized as a significant opportunity to combine the strengths of both organizations, allowing for the delivery of higher value-added services and the creation of new business opportunities.

Details of the Collaboration

The strategic alliance will encompass several key areas:

1. Collaboration in Digital Marketing: The two companies will work together on digital marketing strategies tailored to healthcare professionals.
2. Joint Development of Digital Content: Focus will be placed on creating digital content specifically for healthcare providers, ensuring it meets their informational needs.
3. Mutual Data Utilization: By leveraging combined data resources, the partners intend to innovate and create new services that will benefit the healthcare sector.
4. Technical Collaboration: The collaboration will also involve associated technical support services, further strengthening the operational capabilities of both entities.

Future Prospects

Through this partnership, Medical Tribune and Alfresa aim to revolutionize the distribution of medical information. Their collaborative efforts are set to enhance the advancement of healthcare, sustain community medicine, and achieve a patient-centered approach in medical practice.

Overview of Alfresa Corporation

• - Name: Alfresa Corporation
• - Representative: Yusuke Fukujin, President
• - Location: 7 Kandamisutoyacho, Chiyoda-ku, Tokyo
• - Established: October 2004
• - Capital: 4,000 million yen
• - Main Business: Wholesale distribution of pharmaceuticals, medical devices, and diagnostic reagents
• - Website: Alfresa

Overview of Medical Tribune Co., Ltd.

• - Name: Medical Tribune Co., Ltd.
• - Representative: Osamu Horikawa, President
• - Location: 3-8-21 Toranomon, Minato-ku, Tokyo, 7th floor, Toranomon 33 Mori Building
• - Established: November 1967
• - Capital: 10 million yen
• - Main Business: Management of medical media, planning and management of events and seminars, conducting research projects, and supporting physician career transitions and clinic succession
• - Website: Medical Tribune

For inquiries regarding this announcement, please contact:
Medical Tribune Co., Ltd.
Attn: Corporate Group, Management Department
Phone: 03-6841-4535
Email: [email protected]